Table 3 Multivariable analysis of overall survival

From: A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria

 

Hazard ratio

95% CI

p

UKMRC cytogenetic risk category

1.4

1.1–2

0.006

Erythroid predominance

0.96

0.7–1.2

0.8

WHO Diagnosis (AML-MRC, AML-NOS, or t-AML)

1.06

0.9–1.2

0.36

Back to article page